Elderly NSCLC/D vs DP (JCOG0207)

• Status: Terminated
• Trial end date: 2007-04-01

Summary

To evaluate the efficacy of docetaxel-cisplatin combination in comparison to docetaxel alone for elderly patients with advanced non-small-cell lung cancer.

• Phase: Phase 3

Details

• Lead Sponsor: Japan Clinical Oncology Group
• Collaborator: Ministry of Health, Labour and Welfare, Japan
• Treatments: Cisplatin; Docetaxel